A Life-Saving Procedure: Hybrid Catheter Ablation and LVAD Implantation for a High-Risk Patient
Background
The use of left ventricular assist devices (LVADs) in patients with end-stage heart failure and preoperative ventricular arrhythmias (VAs) is a topic of ongoing debate. These patients often face challenges like hemodynamic instability and limited donor resources, making heart transplantation difficult.
Case Study
A 59-year-old woman with hypertrophic cardiomyopathy and end-stage heart failure experienced recurrent ventricular tachycardia (VT) that didn't respond to medication or electrical cardioversion. The team decided on a single-stage, minimally invasive approach: VT radiofrequency ablation, atrial septal defect (ASD) closure, and LVAD implantation.
Procedure and Outcome
The patient underwent VT radiofrequency ablation, ASD closure, and LVAD implantation. Post-op, she experienced VT recurrence on day 4, which was resolved with amiodarone. She was extubated on day 2 and discharged on day 21. At the 15-month follow-up, she maintained an improved quality of life without sustained VT episodes and stable cardiac function.
Discussion
LVADs have become a crucial treatment for end-stage heart failure, but postoperative VAs remain a common issue. The hybrid minimally invasive strategy used in this case showed promising results as a bridge or destination therapy for high-risk patients with refractory arrhythmias and transplant difficulties.
Controversy and Future Directions
The question remains: should LVAD implantation be considered for patients with preoperative frequent VAs? While LVADs can reduce VAs, postoperative recurrence is a concern. For high-risk patients with limited donor access, LVADs might be a viable option. This case highlights the potential of a hybrid minimally invasive approach, but long-term outcomes need further study.
What are your thoughts on this innovative procedure? Do you think it should be considered more widely for high-risk patients?
